Carolin Schneider discusses how AATD reshapes liver disease risk, highlighting genetic testing as a tool for risk stratification and prevention, and outlining a more proactive, prevention‑focused care pathway for patients
Carole, you and your music mean more to me than I could ever sum up in a speech or a performance. But I TRIED. #RockHall2021# tomorrow at 8pm ET
📷: @GettyImages